nadp has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albahkali, S; Aldossary, W; Alghamdi, A; Alotaibi, B; Alrfaei, BM | 1 |
| Bujalska, IJ; Cooper, MS; Draper, N; Hewison, M; Lavery, GG; Stewart, PM; Tomlinson, JW; Walker, EA | 1 |
1 review(s) available for nadp and Glaucoma
| Article | Year |
|---|---|
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Amino Acid Sequence; Animals; Carbohydrate Dehydrogenases; Cloning, Molecular; Cortisone Reductase; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glaucoma; Glucocorticoids; Humans; Hydrocortisone; Molecular Sequence Data; Mutation; NADP; Obesity; Organ Specificity; Osteoporosis; Recombinant Proteins; Sequence Alignment; Substrate Specificity; Transcription, Genetic | 2004 |
1 other study(ies) available for nadp and Glaucoma
| Article | Year |
|---|---|
The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu).
Topics: Amino Acid Substitution; Animals; Apoptosis; Astrocytes; Cell Proliferation; Cells, Cultured; CRISPR-Cas Systems; Cytochrome P-450 CYP1B1; Cytokines; Glaucoma; Humans; Male; Mesenchymal Stem Cells; Microglia; Models, Animal; NADP; Point Mutation; Rats | 2020 |